White & Case LLP has advised Morgan Stanley as Sole Global Coordinator and Joint Bookrunner, and Credit Suisse as Joint Bookrunner, on the sale to institutional investors by Timone Fiduciaria S.p.A. of 7,537,998 ordinary shares in Azimut Holding S.p.A.

The share sale corresponds to approximately 5.26% of the share capital in Azimut and has been carried out through an accelerated book build for an aggregate value of approximately €210 million.

Norton Rose Fulbright has advised China Taiping Insurance Holdings Company Limited (“China Taiping”) on a US$1.74 billion private placement of shares. China Taiping is a large state-owned financial institution and is listed on the main board of the Hong Kong Stock Exchange.

Charles Russell Speechlys’ Advisory team recently acted as the legal adviser to Mithras Investment Trust plc (the “Company”) on its fourth tender offer, which was announced to shareholders on 19 May 2015.

The fourth tender offer follows on from the Company’s announcement in December 2012 that it intended to enter into a series of tender offers to achieve its core realisation strategy of returning capital to shareholders.

Clifford Chance has advised Gateway Lifestyle on its AUD$500 million initial public offering (IPO). Gateway Lifestyle is expected to be admitted to the Australian Securities Exchange with an official listing on 11 June 2015. The IPO is underwritten and managed by Macquarie and UBS.

Gateway Lifestyle is a market leader in the manufactured home estate (MHE) market. Since 2009, Gateway Lifestyle's portfolio has grown to 36 MHEs and is one of Australia's largest MHE operators, providing affordable living solutions to thousands of senior Australians.

NautaDutilh has assisted its long time client Cofinimmo (REIT - Euronext Brussels) on its 285mio EUR rights issue which closed in May 2015. BNP Paribas Fortis, KBC Securities and ING Belgium acted as joint bookrunners. This is the largest ECM transaction to date in 2015 on Euronext Brussels.

The team of NautaDutilh was led by Nicolas de Crombrugghe and was composed of Dorothée Vanderhofstadt, Harry Eliaerts, Lorraine Vercauteren and Pierre De Pauw.

NautaDutilh has assisted clinical-stage biotech company Galapagos (Euronext Brussels and Euronext Amsterdam) on its 280mio EUR NASDAQ IPO, which closed in May 2015. The global offering was composed of a public offering in the United States of ordinary shares in the form of American Depositary Shares and a concurrent private placement of ordinary shares in Europe. Morgan Stanley, Credit Suisse and Cowen and Company acted as joint bookrunners.

Ashurst is advising Atlas Iron Limited (Atlas) on an innovative costs arrangements and proposed A$180 million capital raising. Atlas is the fourth largest iron ore producer in Australia.

Linklaters has advised Unicreditbank AG’s with its HypoVereinsbank brand on the sale of its 7.09 million shares in Wüstenrot & Württembergische AG. The divestment was implemented by the Berenberg Bank as sole global coordinator in an international placement with institutional investors by means of an accelerated bookbuilding process. Due to the strong demand the entire share block could be successfully placed.

Osborne Clarke has advised Cantor Fitzgerald Europe in its capacity as nominated adviser, broker and sole book runner on the successful AIM IPO of Stride Gaming plc (Stride) which raised approximately £10 million for the Company.

Stride is a UK focussed, real money, bingo-led online games operator. The IPO became effective today (19th May 2015), valuing Stride at approximately £70 million.

The Osborne Clarke team was led by corporate finance Partner Jonathan King who was assisted by Senior Associate Samantha Myers.

Simmons & Simmons is advising J.P. Morgan Securities plc (“J.P. Morgan Cazenove”) and Peel Hunt LLP (“Peel Hunt”) as joint sponsors and joint bookrunners on a £275m Placing and Open Offer by Circassia Pharmaceuticals plc (“Circassia”).

Circassia, the speciality biopharmaceutical company, announced on 15 May 2015 a Placing and Open Offer to raise approximately £275m through the issue of 95,469,537 new ordinary shares, representing 50.4% of its existing issued share capital.